{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,13]],"date-time":"2026-11-13T09:52:47Z","timestamp":1794563567280,"version":"4.9.1"},"reference-count":28,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2006,12,1]],"date-time":"2006-12-01T00:00:00Z","timestamp":1164931200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2006,12,1]],"date-time":"2006-12-01T00:00:00Z","timestamp":1164931200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,12,8]],"date-time":"2022-12-08T00:00:00Z","timestamp":1670457600000},"content-version":"vor","delay-in-days":5851,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["jthjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Thrombosis and Haemostasis"],"published-print":{"date-parts":[[2006,12]]},"DOI":"10.1111\/j.1538-7836.2006.02194.x","type":"journal-article","created":{"date-parts":[[2006,11,9]],"date-time":"2006-11-09T10:18:04Z","timestamp":1163067484000},"page":"2593-2598","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":60,"title":["Inhibition of tissue factor expression by hydroxyurea in polymorphonuclear leukocytes from patients with myeloproliferative disorders: a new effect for an old drug?"],"prefix":"10.1016","volume":"4","author":[{"given":"N.","family":"MAUGERI","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.","family":"GIORDANO","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.P.","family":"PETRILLI","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V.","family":"FRATICELLI","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.","family":"DE GAETANO","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"CERLETTI","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"STORTI","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.B.","family":"DONATI","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1111\/j.1538-7836.2006.02194.x_bb0010","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.1111\/j.1538-7836.2006.01968.x","article-title":"Human polymorphonuclear leukocytes produce and express tissue factor upon stimulation","volume":"4","author":"Maugeri","year":"2006","journal-title":"J Thromb Haemost"},{"key":"10.1111\/j.1538-7836.2006.02194.x_bb0015","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/S0049-3848(02)00354-7","article-title":"Markers of platelet activation and platelet\u2010leukocyte interaction in patients with myeloproliferative syndromes","volume":"108","author":"Villmow","year":"2002","journal-title":"Thromb Res"},{"key":"10.1111\/j.1538-7836.2006.02194.x_bb0020","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1016\/j.exphem.2005.01.015","article-title":"Leukocyte\u2010platelet interaction in patients with essential thrombocythemia and polycythemia vera","volume":"33","author":"Falanga","year":"2005","journal-title":"Exp Hematol"},{"key":"10.1111\/j.1538-7836.2006.02194.x_bb0025","first-page":"169","article-title":"Increased platelet and leukocyte activation as contributing mechanisms for thrombosis in essential thrombocythemia and correlation with the JAK2 mutational status","volume":"91","author":"Arellano\u2010Rodrigo","year":"2006","journal-title":"Haematologica"},{"key":"10.1111\/j.1538-7836.2006.02194.x_bb0030","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1532\/IJH97.E0316","article-title":"Markers of endothelial and in vivo platelet activation in patients with essential thrombocythemia and polycythemia vera","volume":"79","author":"Karakantza","year":"2004","journal-title":"Int J Hematol"},{"key":"10.1111\/j.1538-7836.2006.02194.x_bb0035","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1111\/j.1365-2141.2004.05277.x","article-title":"Thrombosis and haemorrhage in polycythaemia vera and essential thrombocythaemia","volume":"128","author":"Elliott","year":"2005","journal-title":"Br J Haematol"},{"key":"10.1111\/j.1538-7836.2006.02194.x_bb0040","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.1056\/NEJM199504273321704","article-title":"Hydroxyurea for patients with essential thrombocythemia and a high risk of thrombosis","volume":"332","author":"Cortelazzo","year":"1995","journal-title":"N Engl J Med"},{"key":"10.1111\/j.1538-7836.2006.02194.x_bb0045","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1056\/NEJMoa043800","article-title":"Hydroxyurea compared with anagrelide in high\u2010risk essential thrombocythemia","volume":"353","author":"Harrison","year":"2005","journal-title":"N Engl J Med"},{"key":"10.1111\/j.1538-7836.2006.02194.x_bb0050","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1056\/NEJMe058093","article-title":"When and how to treat essential thrombocythemia","volume":"353","author":"Barbui","year":"2005","journal-title":"N Engl J Med"},{"key":"10.1111\/j.1538-7836.2006.02194.x_bb0055","doi-asserted-by":"crossref","first-page":"2297","DOI":"10.1182\/blood.V99.7.2297","article-title":"Hydroxyurea corrects the dysregulated L\u2010selectin expression and increased H(2)O(2) production of polymorphonuclear neutrophils from patients with sickle cell anemia","volume":"99","author":"Benkerrou","year":"2002","journal-title":"Blood"},{"key":"10.1111\/j.1538-7836.2006.02194.x_bb0060","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1002\/1096-8652(200010)65:2<93::AID-AJH1>3.0.CO;2-4","article-title":"Circulating platelet\u2010polymorphonuclear leukocyte aggregates in patients with heart valve replacement","volume":"65","author":"Maugeri","year":"2000","journal-title":"Am J Hematol"},{"key":"10.1111\/j.1538-7836.2006.02194.x_bb0065","first-page":"833","article-title":"Prevention of platelet\u2010polymorphonuclear leukocyte interactions: new clues to the antithrombotic properties of parnaparin, a low molecular weight heparin","volume":"90","author":"Maugeri","year":"2005","journal-title":"Haematologica."},{"key":"10.1111\/j.1538-7836.2006.02194.x_bb0070","doi-asserted-by":"crossref","first-page":"4183","DOI":"10.1182\/blood.V88.11.4183.4183","article-title":"Platelet\/polymorphonuclear leukocyte interaction in dynamic conditions: evidence of adhesion cascade and cross talk between P\u2010selectin and the beta 2 integrin CD11b\/CD18","volume":"88","author":"Evangelista","year":"1996","journal-title":"Blood"},{"key":"10.1111\/j.1538-7836.2006.02194.x_bb0075","doi-asserted-by":"crossref","first-page":"1533","DOI":"10.1182\/blood.V91.5.1533","article-title":"A bioavailability and pharmacokinetic study of oral and intravenous hydroxyurea","volume":"91","author":"Rodriguez","year":"1998","journal-title":"Blood"},{"key":"10.1111\/j.1538-7836.2006.02194.x_bb0080","doi-asserted-by":"crossref","first-page":"1690","DOI":"10.1161\/01.ATV.0000085629.23209.AA","article-title":"Platelet activation induces cell\u2010surface immunoreactive tissue factor expression, which is modulated differently by antiplatelet drugs","volume":"23","author":"Camera","year":"2003","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1111\/j.1538-7836.2006.02194.x_bb0085","doi-asserted-by":"crossref","first-page":"8767","DOI":"10.1073\/pnas.91.19.8767","article-title":"P\u2010selectin induces the expression of tissue factor on monocytes","volume":"91","author":"Celi","year":"1994","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1111\/j.1538-7836.2006.02194.x_bb0090","doi-asserted-by":"crossref","first-page":"4261","DOI":"10.1182\/blood.V96.13.4261","article-title":"Polymorphonuclear leukocyte activation and hemostasis in patients with essential thrombocythemia and polycythemia vera","volume":"96","author":"Falanga","year":"2000","journal-title":"Blood"},{"key":"10.1111\/j.1538-7836.2006.02194.x_bb0095","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1034\/j.1600-0609.2001.00359.x","article-title":"Increased circulating platelet\u2010leukocyte aggregates in myeloproliferative disorders is correlated to previous thrombosis, platelet activation and platelet count","volume":"66","author":"Jensen","year":"2001","journal-title":"Eur J Haematol"},{"key":"10.1111\/j.1538-7836.2006.02194.x_bb0100","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1046\/j.1365-2141.2003.04770.x","article-title":"Increased CD11b neutrophil expression in Budd\u2010Chiari syndrome or portal vein thrombosis secondary to polycythaemia vera","volume":"124","author":"Alvarez\u2010Larran","year":"2004","journal-title":"Br J Haematol"},{"key":"10.1111\/j.1538-7836.2006.02194.x_bb0105","first-page":"1","article-title":"Mechanism of action of hydroxyurea","volume":"19","author":"Yarbro","year":"1992","journal-title":"Semin Oncol"},{"key":"10.1111\/j.1538-7836.2006.02194.x_bb0110","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1182\/blood.V98.1.108","article-title":"Platelet\/polymorphonuclear leukocyte adhesion: a new role for SRC kinases in Mac\u20101 adhesive function triggered by P\u2010selectin","volume":"98","author":"Piccardoni","year":"2001","journal-title":"Blood"},{"key":"10.1111\/j.1538-7836.2006.02194.x_bb0115","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1097\/01.moh.0000190108.62414.06","article-title":"Leukocyte adhesion and the pathophysiology of sickle cell disease","volume":"13","author":"Okpala","year":"2006","journal-title":"Curr Opin Hematol"},{"key":"10.1111\/j.1538-7836.2006.02194.x_bb0120","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1161\/01.ATV.0000156877.94472.a5","article-title":"Leukocytosis and ischemic vascular disease morbidity and mortality: is it time to intervene","volume":"25","author":"Coller","year":"2005","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1111\/j.1538-7836.2006.02194.x_bb0125","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1172\/JCI0214996","article-title":"Heparin's anti\u2010inflammatory effects require glucosamine 6\u2010O\u2010sulfation and are mediated by blockade of L\u2010 and P\u2010selectins","volume":"110","author":"Wang","year":"2002","journal-title":"J Clin Invest"},{"key":"10.1111\/j.1538-7836.2006.02194.x_bb0130","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/S0891-5849(96)00329-2","article-title":"Chemiluminescence from human polymorphonuclear leukocytes activated with opsonized zymosan","volume":"22","author":"Ushijima","year":"1997","journal-title":"Free Radic Biol Med"},{"key":"10.1111\/j.1538-7836.2006.02194.x_bb0135","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1097\/01.moh.0000208470.86732.b4","article-title":"Essential thrombocythemia: scientific advances and current practice","volume":"13","author":"Tefferi","year":"2006","journal-title":"Curr Opin Hematol"},{"key":"10.1111\/j.1538-7836.2006.02194.x_bb0140","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/0049-3848(87)90443-9","article-title":"Intraplatelet levels of vWF:Ag and fibrinogen in myeloproliferative disorders","volume":"48","author":"Meschengieser","year":"1987","journal-title":"Thromb Res"},{"key":"10.1111\/j.1538-7836.2006.02194.x_bb0145","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1159\/000207887","article-title":"Influence of cytostatics on some platelet functions in vitro","volume":"57","author":"Kubisz","year":"1977","journal-title":"V Hydroxyurea. Acta Haematol"}],"container-title":["Journal of Thrombosis and Haemostasis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1538-7836.2006.02194.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S153878362211785X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S153878362211785X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1111\/j.1538-7836.2006.02194.x\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T02:39:17Z","timestamp":1761532757000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S153878362211785X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,12]]},"references-count":28,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2006,12]]}},"alternative-id":["S153878362211785X"],"URL":"https:\/\/doi.org\/10.1111\/j.1538-7836.2006.02194.x","relation":{},"ISSN":["1538-7836"],"issn-type":[{"value":"1538-7836","type":"print"}],"subject":[],"published":{"date-parts":[[2006,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Inhibition of tissue factor expression by hydroxyurea in polymorphonuclear leukocytes from patients with myeloproliferative disorders: a new effect for an old drug?","name":"articletitle","label":"Article Title"},{"value":"Journal of Thrombosis and Haemostasis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1111\/j.1538-7836.2006.02194.x","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2006 International Society on Thrombosis and Haemostasis. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}